The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial.
 
Salah-Eddin Al-Batran
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Lilly; Merck; Roche; SERVIER
Speakers' Bureau - Celgene; Lilly; Nordic Bioscience; Roche
Research Funding - Celgene; Hospira; Lilly; Medac; Novartis; Roche Pharma AG; Vifor Pharma
 
Nils Homann
Consulting or Advisory Role - Amgen; Celgene; Lilly; Roche; Sanofi
 
Harald Schmalenberg
Consulting or Advisory Role - Baxalta; Lilly
Research Funding - Sanofi
Travel, Accommodations, Expenses - Merck
 
Hans-Georg Kopp
No Relationships to Disclose
 
Georg Martin Haag
Consulting or Advisory Role - Lilly; Nordic Bioscience; Pfizer; Roche; Sanofi; Taiho Pharmaceutical
Research Funding - Nordic Bioscience (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Amgen; Celgene; Ipsen
 
Kim Barbara Luley
Travel, Accommodations, Expenses - Ipsen; Novartis; Sanofi
 
Wolff H. Schmiegel
Consulting or Advisory Role - 4SC; AiCuris; Amgen; Apceth; AstraZeneca; Indivumed; Merck Serono; Roche
Research Funding - see link: http://www.medunikkh.de/aerzte/studien/ (Inst)
Patents, Royalties, Other Intellectual Property - Biomarker für die Diagnose von Pankreaskrebs Internationale Patentanmeldung PCT/DE2007/002174 Anmelder: Prof. Dr. Schmiegel, Prof. Dr. S. Hahn, Prof. Dr. H.E. Meyer, Dr. Sitek, Dr. K. Stühler, Dr. Bence-Sipos, Prof. Dr. Klöppel, Dr. Alkatout; Biomarker für hepatische Fibrose Patentanmeldung Deutschland: DE 10 2006 048249.2. Internationale Patentanmeldung PCT/DE 2007001427 Anmelder: Prof. Dr. W. Schmiegel, Dr. C. Mölleken, Dr. Bence-Sipos, Prof. Dr. Klöppel, Prof. Dr. H.E. Meyer, Dr. K. Stühl; Buproprion – Verwendung von Bupropion in Arzneimittel zur Behandlung von Hepatitis C Patentanmeldung Deutschland: DE 10 2004 063 132.8-41 Anmelder: Prof. Dr. W. Schmiegel; Diagnoseverfahrung und Verwendung von MicroRNA Patentanmeldung Deutschland 10 2010 046 866.5 Anmelder: Dr. A. Baraniskin, Prof. Dr. U. Schlegel, Prof. Dr. W. Schmiegel, PD Dr. R. Schroers; Immunoscreening of the Extracellular Proteome of Colorectal Cancer Cells Patentanmeldung USA US 61/176,353 Anmelder: Prof. Dr. W. Schmiegel, Prof. Dr. H.E. Meyer; Lösliches Cadherin 17 für die Diagnose und Risikostratifizierung von Darmtumor und Darmkrebs Internationale Patentanmeldung: PCT/DE2008/001220 Anmelder: Hanna Diehl, Dr. Kai Stühler, Prof. Dr. H. E. Meyer, Dr. S. Klein-Scory, PD Dr. I. Schwarte-Waldho; Pantumormarker Patentanmeldung Deutschland 10 2011 108 254.2 Anmelder: Prof. Dr. W. Schmiegel, Prof. Dr. Stephan Hahn, Dr. Alexander Baraniskin; Statine/HMG-CoA Reduktase Hemmer zur Herstellung von Mitteln, die sich zur Primär- und Sekundärprävention sowie zur Behandlung von hyperplastischen oder dysplastischen Dickdarmpolypen eignen. Patentanmeldung Deutschland DE 10 2004 036 907.0-41 Anmelder:
Travel, Accommodations, Expenses - Abbott; Deutscher Ärzteverlag; Dres. Schlegel + Schmidt; Falk Foundation; GSB Pharma; Labor Berlin-Charité Vivantes Services GmbH; Lilly; MedCongress; Merck Serono; Miami Cancer Institute; Pfizer; Roche; Sanofi; Siemens Healthineers
 
Gunnar Folprecht
Honoraria - Merck KGaA
Consulting or Advisory Role - Baxalta; Bristol-Myers Squibb; Lilly/ImClone; Merck KGaA; Roche/Genentech
Research Funding - Merck KGaA
 
Stephan Probst
No Relationships to Disclose
 
Nicole Prasnikar
No Relationships to Disclose
 
Peter C. Thuss-Patience
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; MSD; Nordic Bioscience; Pfizer; Roche
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Merck; Roche; Teva
 
Wolfgang Fischbach
No Relationships to Disclose
 
Jorg Trojan
No Relationships to Disclose
 
Michael Koenigsmann
Honoraria - Celgene; Novartis
Consulting or Advisory Role - Celgene; Novartis
Travel, Accommodations, Expenses - Novartis
 
Claudia Pauligk
No Relationships to Disclose
 
Thorsten Oliver Goetze
Honoraria - Celgene; MSD
Consulting or Advisory Role - Baxalta; Bristol-Myers Squibb
 
Elke Jaeger
No Relationships to Disclose
 
Johannes Meiler
Consulting or Advisory Role - Novartis; Pfizer; Sanofi
 
Martin H. Schuler
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Novartis; Roche
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis
Patents, Royalties, Other Intellectual Property - Universtity Hospital Essen
 
Ralf Hofheinz
No Relationships to Disclose